In virtro diagnostic substances, reagents, test kits and sets
Ended Awarded
- Contract number
- HHSN26300180
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,151
Award facts
- Contract value 100% obligated
- $6,150.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- CHRISTIANSBRG, VA 24068, USA
Award details come from SAM.gov/FPDS.
About this award
Qiagen, LLC was awarded a Blanket Purchase Agreement (BPA) call valued at $6,150.72 for in vitro diagnostic substances, reagents, test kits, and sets on March 26, 2018, with an ultimate completion date of April 30, 2018. The contract was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, and is designated as Firm Fixed Price with no set-aside used. Performance will be conducted in Christiansburg, Virginia. As a child entity of Qiagen N.V., a Netherlands-based multinational biotechnology company, Qiagen, LLC specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions and has established a substantial portfolio of federal contracts across multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs.
This BPA call represents a task order issued under one of Qiagen's existing Indefinite Delivery Vehicles with the federal government. The company's broader federal contract portfolio demonstrates consistent capability in supplying specialized reagents, consumables, and diagnostic testing kits to support critical research, healthcare, and public health initiatives. Qiagen's molecular diagnostics offerings, including tuberculosis testing reagents, DNA/RNA extraction kits, and associated laboratory instrumentation, are widely utilized across federal agencies for biomedical research and clinical diagnostic applications. The relatively modest value of this particular call is consistent with typical task order amounts drawn from larger BPA vehicles established to streamline recurring procurement needs.
Quick answers
Who was awarded contract HHSN26300180?
HHSN26300180 was awarded to Qiagen, LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on March 26, 2018.
How much is contract HHSN26300180 worth?
The government has obligated $6,151 on HHSN26300180.
Is contract HHSN26300180 an order under another contract?
Yes. HHSN26300180 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN26300180 competed?
The extent of competition for HHSN26300180 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award